Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamineinjected mice

Molecular Medicine Reports

Volumn 11, Issue 2, 2015, Pages 887-895

  Shen, Cheng Huang ^a   Wang, Shou Tsung ^b   Lee, Ying Ray ^a,c   Liu, Shiau Yuan ^b   Li, Yi Zhen ^b   Wu, Jiann Der ^a   Chen, Yi Ju ^a   Liu, Yi Wen ^b  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^c Min Hwei College of Health Care Management   (Taiwan)

Author keywords

Bladder; Cytotoxicity; Gene expression profiling; Keratin; Ketamine

Indexed keywords

ANIMALIA; MUS;

ANALGESIC AGENT; KERATIN; KETAMINE;

ANIMAL; BAGG ALBINO MOUSE; BLADDER; BODY WEIGHT; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE; PATHOLOGY; PERMEABILITY;

ANALGESICS; ANIMALS; BODY WEIGHT; CELL LINE; CELL SURVIVAL; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KETAMINE; MALE; MICE; MICE, INBRED BALB C; PERMEABILITY; URINARY BLADDER;

EID: 84916197816     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2823     Document Type: Article

References (27)

1. Domino EF, Chodoff P and Corssen G: Pharmacologic effects of Ci-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther 6: 279-291, 1965.
2. Sinner B and Graf BM: Ketamine. Handb Exp Pharmacol: 313-333, 2008.
3. Ivani G, Vercellino C and Tonetti F: Ketamine: a new look to an old drug. Minerva Anestesiol 69: 468-471, 2003.
4. Domino EF: Taming the ketamine tiger. 1965. Anesthesiology 113: 678-684, 2010.
5. Chu PS, Kwok SC, Lam KM, et al: Street ketamine-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13: 311-313, 2007.
6. Shahani R, Streutker C, Dickson B and Stewart RJ: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69: 810-812, 2007.
7. Ng SH, Tse ML, Ng HW and Lau FL: Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J 16: 6-11, 2010.
8. Tsai TH, Cha TL, Lin CM, et al: Ketamine-associated bladder dysfunction. Int J Urol 16: 826-829, 2009.
9. Middela S and Pearce I: Ketamine-induced vesicopathy: a literature review. Int J Clin Pract 65: 27-30, 2011.
10. Chen CH, Lee MH, Chen YC and Lin MF: Ketamine-snorting associated cystitis. J Formos Med Assoc 110: 787-791, 2011.
11. Yeung LY, Rudd JA, Lam WP, Mak YT and Yew DT: Mice are prone to kidney pathology after prolonged ketamine addiction. Toxicol Lett 191: 275-278, 2009.
12. Meng E, Chang HY, Chang SY, et al: Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction. J Urol 186: 1134-1141, 2011.
13. Gu D, Huang J, Shan Z, et al: Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system. Int J Urol 20: 1024-1031, 2013.
14. Chuang SM, Liu KM, Li YL, et al: Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder. Neurourol Urodyn 32: 1137-1143, 2013.
15. Rigby CC and Franks LM: A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br J Cancer 24: 746-754, 1970.
16. Fogh J, Fogh JM and Orfeo T: One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226, 1977.
17. Mak YT, Lam WP, Lu L, Wong YW and Yew DT: The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron. Microsc Res Tech 73: 195-201, 2010.
18. Braun S, Gaza N, Werdehausen R, et al: Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells. Br J Anaesth 105: 347-354, 2010.
19. Lee ST, Wu TT, Yu PY and Chen RM: Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria-caspase protease pathway. Br J Anaesth 102: 80-89, 2009.
20. Lee CL, Jiang YH and Kuo HC: Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls. BJU Int 112: 1156-1162, 2013.
21. Harnden P, Eardley I, Joyce AD and Southgate J: Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 78: 870-875, 1996.
22. Oxley JD, Cottrell AM, Adams S and Gillatt D: Ketamine cystitis as a mimic of carcinoma in situ. Histopathology 55: 705-708, 2009.
23. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T and Cordon-Cardo C: Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 28: 401-408, 2010.
24. Coulombe PA, Kerns ML and Fuchs E: Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. J Clin Invest 119: 1784-1793, 2009.
25. Arifi M, Arifi S, Demni K, et al: Genitourinary complications as initial presentation of inherited epidermolysis bullosa. Afr J Paediatr Surg 8: 72-74, 2011.
26. Alam H, Sehgal L, Kundu ST, Dalal SN and Vaidya MM: Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells. Mol Biol Cell 22: 4068-4078, 2011.
27. Mercurio AM: Laminin receptors: achieving specificity through cooperation. Trends Cell Biol 5: 419-423, 1995.